Laga assists Bioqube Ventures with launch as specialist investment firm and collaboration with Johnson & Johnson Innovation

Laga assisted Bioqube Ventures with its launch as specialist investment firm, as well as with its collaboration with Johnson & Johnson Innovation in launching JLINX, which will offer scientists and entrepreneurs access to venture funding, R&D expertise and state-of-the-art facilities.

Bioqube ventures is an independent new venture that aims to identify, coach and nurture new investment opportunities.

Christoph Michiels from the Corporate - M&A practice was lead for Laga, with the team including Olivier Van Borsel.

For more information: www.bioqubeventures.com and www.jnjinnovation.com